Monica Mita, MD

Trials

Studies that name Monica Mita, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:44 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT03822715 · NEOBREADS: Neoadjuvant Breast Diet Study

  Monica Mita · terminated · Breast Cancer · principal investigator
• N/A
  NCT03098576 · Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute

  Cedars-Sinai Medical Center · completed · Cancer · principal investigator
• Ph1
  NCT01588522 · Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia

  BPGbio · completed · Chemotherapy-Induced Alopecia · principal investigator
• Ph1
  NCT01296659 · Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

  The University of Texas Health Science Center at San Antonio · withdrawn · Soft Tissue Sarcoma · principal investigator
• Ph1
  NCT00937417 · S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

  SWOG Cancer Research Network · withdrawn · Breast Cancer, Head and Neck Cancer, Lung Cancer · study chair
• Ph2
  NCT00753038 · Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

  Oncolytics Biotech · completed · Carcinoma, Squamous Cell of the Head and Neck · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.